Alan Aspuru-Guzik has managed, at a young age, to co-found four tech/biotech startups, is professor of chemistry and computer science at the University of Toronto, and sits on the boards of AI-driven biotech, Insilico Medicine. It would be challenging to identify his main project, as he is also chair of Toronto’s Vector Institute for Artificial Intelligence and director of Acceleration Consortium, two projects meant to guide the roll out of artificial intelligence safely and effectively, across a swath of industrial sectors and by a range of global stakeholders.
In this episode of the In Vivo podcast, Alan focuses on the value of generative AI, automation and quantum computing in drug discovery.
Timestamp:
Intro
1:20 - Aspuru-Guzik’s academic and career trajectory
3:40 - Generative AI for molecule creation
6:30 - Intrepid Labs: a self-driving lab that combines automation with machine learning to optimize drug formulation
11:10 - Collaborations with pharma, including work with Insilico Medicine
13:40 - The creative potential of generative AI in drug discovery
16:20 - Quantum computing and pharma
19:30 - Combining quantum power with the self-driving lab
22:00 - Ethics in pharma
26:30 - The future of drug discovery and development
